Pressure BioSciences Inc.: Pressure BioSciences, Inc. Reports Q3 2022 Financial Results and Offers Business Update on Ultra Shear Technology Nanoemulsions Commercialization Progress
Resources Continue to Pivot to UST Platform Commercialization, Achieving Major Progress and Traction; Revolutionary Nanoemulsions Technology Expected to Drive Major Growth to Profitability in 2023Investor
United States Johnb Hollister Denese Skinscience Richardt Schumacher Jeffreyn Peterson Adrienne Denese
Source: finanznachrichten.de